AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 141 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $221,000 | +67.4% | 23,545 | +36.5% | 0.00% | +100.0% |
Q2 2020 | $132,000 | +25.7% | 17,252 | +1.1% | 0.00% | 0.0% |
Q1 2020 | $105,000 | -25.0% | 17,064 | +48.4% | 0.00% | 0.0% |
Q4 2019 | $140,000 | +5.3% | 11,498 | -0.0% | 0.00% | 0.0% |
Q3 2019 | $133,000 | +14.7% | 11,499 | -0.6% | 0.00% | 0.0% |
Q2 2019 | $116,000 | -24.2% | 11,565 | -2.9% | 0.00% | -33.3% |
Q1 2019 | $153,000 | -15.0% | 11,914 | +0.6% | 0.00% | -25.0% |
Q4 2018 | $180,000 | -70.0% | 11,842 | +7.9% | 0.00% | -63.6% |
Q1 2015 | $600,000 | -20.8% | 10,980 | -38.2% | 0.01% | 0.0% |
Q4 2014 | $758,000 | – | 17,780 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |